The interaction of butyrate with TNF-α during differentiation and apoptosis of colon epithelial cells: Role of NF-κB activation

Cytokine

Volumn 44, Issue 1, 2008, Pages 33-43

  Hyzd'alova M ^a   Hofmanova J ^a   Pachernik J ^b   Vaculova A ^a   Kozubik A ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Butyrate; Differentiation; NF B; TNF

Indexed keywords

BUTYRIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARTHENOLIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN HT29; CELL TYPE; COLON MUCOSA; HUMAN; HUMAN CELL; IMMUNOPOTENTIATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

APOPTOSIS; BUTYRATES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COLON; DRUG INTERACTIONS; HT29 CELLS; HUMANS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52949121388     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.06.003     Document Type: Article

References (40)

1. Lipkin M., Reddy B., Newmark H., and Lamprecht S.A. Dietary factors in human colorectal cancer. Annu Rev Nutr 19 (1999) 545-586
2. Petronis A., and Petriniene R. Epigenetics of inflammatory bowel disease. Gut 47 (2000) 302-306
3. Lupton J.R. Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr 134 2 (2004) 479-482
4. Bach Knudsen K.E., Serena A., Canibe N., and Juntunen K.S. New insight into butyrate metabolism. Proc Nutr Soc 62 1 (2003) 81-86
5. Pouillart P.R. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies-minireview. Life Sci 63 20 (1998) 1739-1760
6. Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42 (1982) 65-82
7. Scheppach W., Bartram H.P., and Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 31A 7-8 (1995) 1077-1080
8. Reimold A.M. TNFalpha as therapeutic target: new drugs, more applications. Curr Drug Targets Inflamm Allergy 1 4 (2002) 377-392
9. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 43 (1995) 227-235
10. Beletsky I.P., Moshnikova A.B., and Proussakova O.V. Cytotoxic signal transduction pathways via TNF family receptors. Biochemistry (Mosc) 67 3 (2002) 312-328
11. Plevy S.E., Targan S.R., Andus T., and Toyoda H. TNF-alpha mRNA levels differentiate mucosal inflammation in Crohn's disease from ulcerative colitis. J Immunol 150 (1993) 10-16
12. Numata A., Minagawa T., Asano M., Nakane A., Katoh H., and Tanabe T. Functional evaluation of tumor-infiltrating mononuclear cell: detection of endogenous INF-gamma and TNF-alpha in human colorectal adenocarcinomas. Cancer 68 (1991) 1937-1943
13. Baier P.K., Wolff-Vorbeck G., Eggstein S., Baumgartner U., and Hopt U.T. Cytokine expression in colon carcinoma. Anticancer Res 25 3B (2005) 2135-2139
14. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 49 (1999) 6853-6866
15. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25 51 (2006) 6685-6705
16. Butzner J.D., Parmar R., Bell C.J., and Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38 4 (1996) 568-573
17. Segain J.P., Raingeard de la Bletiere D., Bourreille A., Leray V., Gervois N., Rosales C., et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47 3 (2000) 397-403
18. Beg A., and Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274 (1996) 782-793
19. Wu G.D., Huang N., Wen X., Keilbaugh S.A., and Yang H. High-level expression of IkappaB in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role. J Leukoc Biol 66 (1999) 1049-1056
20. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., et al. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 100 21 (2003) 12247-12252
21. Gilmore T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25 51 (2006) 6680-6684
22. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev 18 18 (2004) 2195-2224
23. Place R.F., Noonan E.J., and Giardina C. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochem Pharmacol 70 3 (2005) 394-406
24. Yin L., Laevsky G., and Giardina C. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276 48 (2001) 44641-44646
25. Saksela K., and Baltimore D. Negative regulation of immunoglobulin kappa light-chain gene transcription by a short sequence homologous to the murine B1 repetitive element. Mol Cell Biol 13 6 (1993) 3698-3705
26. Kovarikova M., Pacherník J., Hofmanová J., Zadák Z., and Kozubík A. TNF-alpha modulates the differentiation induced by butyrate in the HT-29 human colon adenocarcinoma cell line. Eur J Cancer 36 (2000) 1844-1852
27. Jones S.A., Butler R.N., Sanderson I.R., and Wilson J.W. The effect of specific caspase inhibitors on TNF-alpha and butyrate-induced apoptosis of intestinal epithelial cells. Exp Cell Res 292 1 (2004) 29-39
28. Giardina C., Boulares H., and Inan M.S. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochim Biophys Acta 1448 (1999) 425-438
29. Luhrs H., Kudlich T., Neumann M., Schauber J., Melcher R., Gostner A., et al. Butyrate-enhanced TNFalpha-induced apoptosis is associated with inhibition of NF-kappaB. Anticancer Res 22 3 (2002) 1561-1568
30. Fajkus J., Borsky M., Kunicka Z., Kovarikova M., Dvorakova D., Hofmanova J., et al. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells. Anticancer Res 23 2B (2003) 1605-1612
31. Baichwal V.R., and Baeuerle P.A. Activate NF-kappa B or die?. Curr Biol 7 2 (1997) R94-R96
32. Zwacka R.M., Stark L., and Dunlop M.G. NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cells. J Gene Med 2 5 (2000) 334-343
33. Rouet-Benzineb P., Aparicio T., Guilmeau S., Pouzet C., Descatoire V., Buyse M., et al. Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling. J Biol Chem 279 16 (2004) 16495-16502
34. Gassull M.A. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease. Aliment Pharmacol Ther 24 Suppl. 3 (2006) 90-95
35. Inan M.S., Rasoilpour R.J., Yin L., Hubbard A.K., Rosenberg D.W., and Giardina C. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 118 (2000) 724-734
36. Bartova E., Pachernik J., Harnicarova A., Kovarik A., Kovarikova M., Hofmanova J., et al. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. J Cell Sci 118 Pt. 21 (2005) 5035-5046
37. Luhrs H., Gerke T., Schauber J., Dusel G., Melcher R., Scheppach W., et al. Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short-chain fatty acid butyrate. Int J Colorectal Dis 16 4 (2001) 195-201
38. Vaculova A., Hofmanova J., Soucek K., Kovarikova M., and Kozubik A. Tumor necrosis factor-alpha induces apoptosis associated with poly(ADP-ribose) polymerase cleavage in HT-29 colon cancer cells. Anticancer Res 22 3 (2002) 1635-1639
39. Hofmanova J., Vaculova A., Hyzd'alova M., and Kozubik A. Response of normal and colon cancer epithelial cells to TNF-family apoptotic inducers. Oncol Rep 19 2 (2008) 567-573
40. Hehner S.P., Hofmann T.G., Droge W., and Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol 163 10 (1999) 5617-5623